HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The use of emakor in arterial ischemia of the lower extremities in outpatient practice].

Abstract
Overall 43 outpatients with arterial ischemia of the lower limbs were treated by emakor, a new Soviet drug that exerts a concomitant alpha- and beta-blocking action. The treatment resulted in a remarkable positive effect which manifested itself in amelioration of circulation in the lower limbs, positive time-course of changes in peripheral hemodynamics and in computer-aided tomography data. The use of emakor is contraindicated in exacerbation of gastrointestinal diseases, chronic pulmonary diseases associated with the obstructive syndrome, and marked signs of venous outflow obstruction in the lower limbs.
AuthorsA A Sviridov, A V Romashkin, T M Terekhova, V S Zadionchenko
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 64 Issue 1 Pg. 44-6 ( 1992) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitlePrimenenie émakora pri arterial'noĭ ishemii nizhnikh konechnosteĭ v ambulatornoĭ praktike.
PMID1355932 (Publication Type: Journal Article)
Chemical References
  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Organic Chemicals
  • Tablets
  • emakor
Topics
  • Adrenergic alpha-Antagonists (therapeutic use)
  • Adrenergic beta-Antagonists (therapeutic use)
  • Aged
  • Ambulatory Care
  • Arteriosclerosis Obliterans (drug therapy)
  • Contraindications
  • Drug Evaluation
  • Drug Tolerance
  • Endarteritis (drug therapy)
  • Female
  • Humans
  • Intermittent Claudication (drug therapy)
  • Ischemia (drug therapy)
  • Leg (blood supply)
  • Male
  • Middle Aged
  • Organic Chemicals
  • Regional Blood Flow (drug effects)
  • Tablets

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: